Switzerland-based Sotax Group, which is into development and manufacture of dissolution testing equipment for the pharmaceutical industry, has introduced a range of equipment called Xtend dissolution line that is aimed at helping pharma companies to improve the quality of their formulations.
The new range, already launched in Europe, will enable pharma companies to know the drug release pattern and help in multi-parameter testing before drugs are released in the market.
“The fully modular and scalable Xtend allows lab scientists to tailor dissolution testing to both their current and future needs. This new concept consists of new individual and standardized Xtend modules such as the AT dissolution bath, the CP pump, the FS filter station and the SAM sample manager which can be flexibly combined for different automation requirements — from manual bath to semi-and fully automated dissolution system,” the company said.
“These two new equipment will be introduced in India in May, 2014. These will help further improve the quality of pharmaceutical formulations of large as well as small and medium pharma companies,” said Lakshmanan Ramaswamy, Managing Director, Sotax India.
Mr.Ramaswami did not reveal the price in India stating that the pricing would depend on the configuration of the equipment. He also declined to disclose the number of units to be sold in India.
Some of the companies which use Sotax’s equipment include Novartis, Johnson & Johnson, Sun Pharma, Glenmark Pharmaceuticals and Lupin Laboratories.
